These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23430253)

  • 21. Label-free Quantitative Proteomics of Mouse Cerebrospinal Fluid Detects β-Site APP Cleaving Enzyme (BACE1) Protease Substrates In Vivo.
    Dislich B; Wohlrab F; Bachhuber T; Müller SA; Kuhn PH; Hogl S; Meyer-Luehmann M; Lichtenthaler SF
    Mol Cell Proteomics; 2015 Oct; 14(10):2550-63. PubMed ID: 26139848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse brain proteomics establishes MDGA1 and CACHD1 as in vivo substrates of the Alzheimer protease BACE1.
    Rudan Njavro J; Klotz J; Dislich B; Wanngren J; Shmueli MD; Herber J; Kuhn PH; Kumar R; Koeglsperger T; Conrad M; Wurst W; Feederle R; Vlachos A; Michalakis S; Jedlicka P; Müller SA; Lichtenthaler SF
    FASEB J; 2020 Feb; 34(2):2465-2482. PubMed ID: 31908000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes.
    van Bebber F; Hruscha A; Willem M; Schmid B; Haass C
    J Neurochem; 2013 Nov; 127(4):471-81. PubMed ID: 23406323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein.
    Murayama KS; Kametani F; Saito S; Kume H; Akiyama H; Araki W
    Eur J Neurosci; 2006 Sep; 24(5):1237-44. PubMed ID: 16965550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BACE2 as a new diabetes target: a patent review (2010 - 2012).
    Southan C
    Expert Opin Ther Pat; 2013 May; 23(5):649-63. PubMed ID: 23506624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BACE2 suppression in mice aggravates the adverse metabolic consequences of an obesogenic diet.
    Díaz-Catalán D; Alcarraz-Vizán G; Castaño C; de Pablo S; Rodríguez-Comas J; Fernández-Pérez A; Vallejo M; Ramírez S; Claret M; Parrizas M; Novials A; Servitja JM
    Mol Metab; 2021 Nov; 53():101251. PubMed ID: 34015524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Mechanism of Binding Selectivity of Inhibitors toward BACE1 and BACE2 Revealed by Multiple Short Molecular Dynamics Simulations and Free-Energy Predictions.
    Chen J; Wang J; Yin B; Pang L; Wang W; Zhu W
    ACS Chem Neurosci; 2019 Oct; 10(10):4303-4318. PubMed ID: 31545898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RCAN1 Inhibits BACE2 Turnover by Attenuating Proteasome-Mediated BACE2 Degradation.
    Qiu K; Wang S; Wang X; Wang F; Wu Y
    Biomed Res Int; 2020; 2020():1920789. PubMed ID: 32566665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BACE1 and BACE2 enzymatic activities in Alzheimer's disease.
    Ahmed RR; Holler CJ; Webb RL; Li F; Beckett TL; Murphy MP
    J Neurochem; 2010 Feb; 112(4):1045-53. PubMed ID: 19968762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of reticulon 3 in neurons leads to reduced axonal transport of β site amyloid precursor protein-cleaving enzyme 1.
    Deng M; He W; Tan Y; Han H; Hu X; Xia K; Zhang Z; Yan R
    J Biol Chem; 2013 Oct; 288(42):30236-30245. PubMed ID: 24005676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.
    Miyamoto M; Kuzuya A; Noda Y; Ueda S; Asada-Utsugi M; Ito S; Fukusumi Y; Kawachi H; Takahashi R; Kinoshita A
    J Alzheimers Dis; 2020; 75(1):173-185. PubMed ID: 32280101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice.
    Dominguez D; Tournoy J; Hartmann D; Huth T; Cryns K; Deforce S; Serneels L; Camacho IE; Marjaux E; Craessaerts K; Roebroek AJ; Schwake M; D'Hooge R; Bach P; Kalinke U; Moechars D; Alzheimer C; Reiss K; Saftig P; De Strooper B
    J Biol Chem; 2005 Sep; 280(35):30797-806. PubMed ID: 15987683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Secretase activity in rat astrocytes: translational block of BACE1 and modulation of BACE2 expression.
    Bettegazzi B; Mihailovich M; Di Cesare A; Consonni A; Macco R; Pelizzoni I; Codazzi F; Grohovaz F; Zacchetti D
    Eur J Neurosci; 2011 Jan; 33(2):236-43. PubMed ID: 21073551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
    Stockley JH; O'Neill C
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6.
    Zhu K; Xiang X; Filser S; Marinković P; Dorostkar MM; Crux S; Neumann U; Shimshek DR; Rammes G; Haass C; Lichtenthaler SF; Gunnersen JM; Herms J
    Biol Psychiatry; 2018 Mar; 83(5):428-437. PubMed ID: 28129943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome.
    Sun X; He G; Song W
    FASEB J; 2006 Jul; 20(9):1369-76. PubMed ID: 16816112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains.
    Causevic M; Dominko K; Malnar M; Vidatic L; Cermak S; Pigoni M; Kuhn PH; Colombo A; Havas D; Flunkert S; McDonald J; Gunnersen JM; Hutter-Paier B; Tahirovic S; Windisch M; Krainc D; Lichtenthaler SF; Hecimovic S
    PLoS One; 2018; 13(7):e0200344. PubMed ID: 29979789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2.
    Fujimoto K; Matsuoka E; Asada N; Tadano G; Yamamoto T; Nakahara K; Fuchino K; Ito H; Kanegawa N; Moechars D; Gijsen HJM; Kusakabe KI
    J Med Chem; 2019 May; 62(10):5080-5095. PubMed ID: 31021626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.